These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 31451207)

  • 1. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
    Kew KM; Karner C; Mindus SM; Ferrara G
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD009019. PubMed ID: 24343671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zheng J; Gustafson P; Lamarca R; Puu M; Keen C; Alagappan VKT; Reddel HK
    Lancet Respir Med; 2021 Feb; 9(2):149-158. PubMed ID: 33010810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C; Naya I; Ekelund J
    Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination budesonide/formoterol inhaler as sole reliever therapy in Māori and Pacific people with mild and moderate asthma.
    Hardy J; Tewhaiti-Smith J; Baggott C; Fingleton J; Semprini A; Holliday M; Hancox RJ; Weatherall M; Harwood M
    N Z Med J; 2020 Aug; 133(1520):61-72. PubMed ID: 32994594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007085. PubMed ID: 19160317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.
    Papi A; Marku B; Scichilone N; Maestrelli P; Paggiaro P; Saetta M; Nava S; Folletti I; Bertorelli G; Bertacco S; Contoli M; Plebani M; Barbaro MPF; Spanevello A; Aliani M; Pannacci M; Morelli P; Beghé B; Fabbri LM;
    Lancet Respir Med; 2015 Feb; 3(2):109-119. PubMed ID: 25481378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
    Bateman ED; Reddel HK; O'Byrne PM; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Siwek-Posluszna A; FitzGerald JM
    N Engl J Med; 2018 May; 378(20):1877-1887. PubMed ID: 29768147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy.
    Buhl R; Kuna P; Peters MJ; Andersson TL; Naya IP; Peterson S; Rabe KF
    Respir Res; 2012 Jul; 13(1):59. PubMed ID: 22816878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Ivanov S; Reddel HK
    N Engl J Med; 2018 May; 378(20):1865-1876. PubMed ID: 29768149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    FitzGerald JM; Arnetorp S; Smare C; Gibson D; Coulton K; Hounsell K; Golam S; Sadatsafavi M
    Respir Med; 2020 Sep; 171():106079. PubMed ID: 32917353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma.
    Beasley R; Harper J; Bird G; Dunphy H; Semprini A; Pavord ID; Papi A; Weatherall M
    BMC Pulm Med; 2019 Dec; 19(1):264. PubMed ID: 31883519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007313. PubMed ID: 19370682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.